Many experts say that patients facing death should get to try last-ditch experimental medications, but there’s disagreement over how exactly to accomplish that.

Since 2014, 30 states have passed “right-to-try” measures allowing drug companies to give terminally ill patients new medications before they are fully approved by the Food and Drug Administration, treatments otherwise available only to patients in clinical trials.

Recommended Stories

What we know about who’s behind the fake polling operation Wedgewood Polls

DOJ urged to investigate Slotkin over threats to young professionals seeking work in Trump administration

Sixth Circuit weighs right for public to see Michigan court recordings after judge accused of verbally abusing defendant